drugset / Trial / NCT00469664
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
Phase 4
Unknown
50 enrolled
Research Foundation for Mental Hygiene, Inc.
Bronx VA Medical Center · collabIcahn School of Medicine at Mount Sinai · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Our overall aim is to determine if the administration of guanfacine in combination with aripiprazole, olanzapine, quetiapine, and/or risperidone is significantly more effective than any of those medications alone in treating some of the cognitive impairment in schizophrenia.
Timeline
- Start
- 2000-02
- Primary completion
- 2008-08
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guanfacine | Small molecule | 3 mg | — |